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Abstract
Background
Ischaemia-reperfusion injury in kidney transplantation leads to delayed graft function (DGF),
which is associated with reduced long term graft function. Remote ischaemic conditioning
(RIC) improved early kidney graft function in a porcine model of donation after brain death
and was associated with improved long-term cardiac outcome after myocardial ischaemia.
This randomised, double-blinded trial evaluated the effect of RIC on kidney graft outcome in
the first year, and examined the predictive value of a new measure of initial kidney graft func-
tion, i.e. the estimated time to a 50% reduction in plasma creatinine post-transplantation
(tCr50).
Methods
A total of 225 patients undergoing deceased donor kidney transplantation were randomised
to RIC or a sham procedure performed prior to kidney reperfusion. Up to four repetitive
cycles of five minutes of leg ischaemia and five minutes of reperfusion were given. GFR,
plasma creatinine, cystatin C and neutrophil gelatinase associated lipocalin (NGAL) were
measured at three and twelve months and estimated GFR was calculated using four differ-
ent equations. Other secondary outcomes were identified from patient files.
Results
RIC did not affect GFR or other outcomes when compared to the sham procedure at three
or twelve months. tCr50 correlated with one year graft function (p<0.0001 for both mGFR
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and eGFR estimates). In contrast, DGF i.e. “need of dialysis the first week” did not correlate
significantly with one year GFR.
Conclusion
RIC during deceased donor kidney transplantation did not improve one year outcome. How-
ever, tCr50 may be a relevant marker for studies aiming to improve graft onset.
Trial registration
www.ClinicalTrials.gov Identifier: NCT01395719.
Introduction
Delayed graft function (DGF) is a consequence of ischaemia-reperfusion injury and a common
complication after deceased donor kidney transplantation [1,2]. It is associated with an
increased incidence of post-transplant complications, acute rejection, reduced long-term graft
outcome and graft loss [3–5].
Remote ischaemic conditioning (RIC) protects against ischaemia-reperfusion injury in var-
ious tissues in both experimental and some clinical studies, particularly in the heart [6,7], but
also in the transplanted kidney in our porcine model [8]. It is believed that RIC sends a protec-
tive signal to a remote organ or tissue that is transferred via humoral, neuronal or other
systemic pathway to the cells in the target organ. RIC applied during myocardial infarction
has been associated with a better long-term outcome when evaluated at a mean of 3.8 years
follow-up [9]. Indeed, in our porcine donation after brain death transplantation model, RIC
improved early glomerular filtration rate (GFR) and renal plasma perfusion [8].
The multi-centre, randomised, controlled clinical study CONTEXT [10] evaluated the
effect of recipient RIC in deceased donor kidney transplantation. Many definitions of delayed
graft function have been proposed based on reduction of creatinine level or need for dialysis
[11]. As previously published, RIC had no effect on early kidney graft function measured as
the estimated time to a 50% reduction in plasma (P-) creatinine (tCr50) [12] or the incidence
of DGF defined as the need for dialyses within the first week after transplantation [13]. In this
follow up of the CONTEXT study, we evaluated the effect of RIC on kidney graft function,
rejection rate, new onset diabetes after transplantation (NODAT), patient survival, and the
kidney injury marker neutrophil gelatinase associated lipocalin (NGAL) [14,15] at three and
twelve months post-transplantation. We further examined whether tCr50 predicted GFR at
twelve months. GFR was measured and estimated based on P-creatinine and P-cystatin C.
Materials and methods
Study design
The study design of CONTEXT (www.ClinicalTrials.gov Identifier: NCT01395719) was previ-
ously described in detail [10]. A total of 225 adult patients undergoing deceased donor kidney
transplantation were included at four centres: Aarhus, Denmark; Gothenburg, Sweden; and
Groningen and Rotterdam in the Netherlands [13]. All patients provided written informed
consent. The study was approved by the National Committee on Health Research Ethics (Den-
mark), Regional Ethical Board (Sweden) and METCUMCG (the Netherlands).
Remote ischaemic conditioning and one year kidney graft function
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Inclusion criteria were deceased donor kidney transplantation and age� 18 years. Exclu-
sion criteria were double kidney transplant, risk of lower limb ischaemia during RIC, and AV-
fistula in the leg where RIC was performed.
Patients were randomised to receive either RIC or sham-RIC during surgery. The RIC pro-
cedure consisted of up to four cycles of inflation and deflation of a tourniquet around the
thigh contralateral to the transplantation side. This resulted in cycles of five minutes ischaemia
and five minutes reperfusion performed just prior to reperfusion of the kidney. Kidney graft
function was evaluated at three and twelve months post-transplantation. Additional informa-
tion on patient and graft survival, the need for dialysis, rejection episodes and NODAT was
obtained from patient records.
Blood and urine
EDTA-blood and urine samples were collected, centrifuged at 2800G at 4˚C for ten minutes
and stored at -80˚C until further analysed. P-NGAL was measured using a particle-enhanced
turbidimetric immunoassay (1BioPorto A/S, Hellerup, Denmark). P-cystatin C was measured
using a turbidimetric immunoassay (Siemens Healthcare A/S, Ballerup, Denmark). P-creati-
nine, U-creatinine and U-albumin were measured using automated, standard clinical assays at
the Department of Clinical Biochemistry, Aarhus University Hospital. tCr50, which was the
primary end point of the CONTEXT study, was calculated from post-transplant changes in P-
creatinine as previously described [13] and DGF was defined as the need for dialysis within the
first week after transplantation.
Glomerular filtration rate
Measured GFR (mGFR) was determined using 51chrome-ethylenediamine tetraacetic acid
[16] (51Cr-EDTA) or iodothalamate plasma clearance. Estimated GFR (eGFR) was calculated
using the following equations without correction for race (>90% of the patients were Cauca-
sian): a) the simplified MDRD creatinine based formula [17]; b) the CKD-EPI creatinine based
formula (eGFRCr) [18]; c) the CKD-EPI cystatin C based formula (eGFRCys) [19]; and d) the
CKD-EPI creatinine and cystatin C based formula (eGFRCr-Cys) [19].
Statistical analyses
The mGFR, eGFR estimates, and P-NGAL at three and twelve months were analysed using
repeated measurement analysis of variance or linear regression. A linear mixed regression
effects model was used to compare log transformed outcomes between the RIC and sham-RIC
groups, with RIC and centre as fixed effects, and donor as random effect. Data are presented as
n (%), mean (SD), median (IQR) or estimated median (95% CI). The Chi-square test or Fish-
er’s exact test was used to examine the significance of categorical outcomes. Continuous vari-
ables were correlated using simple linear regression. Data were analysed in Stata/IC 12.1 for
Mac (Copyright 1985–2011 Stata-Corp LP, College Station, TX).
Results
Inclusion
225 patients were included from June 12, 2011, to December 28, 2014. Three patients were
withdrawn from the study during the transplant surgery, leaving a total of 222 patients for the
per-protocol analysis (Fig 1).
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RIC did not affect GFR or other outcomes at three months and one year
As previously reported, baseline data, tCr50 and the incidence of DGF were similar in the RIC
and sham-RIC groups (Table 1) [13].
This extended analysis showed that both the three month and one-year graft function were
also similar, with no significant differences either in mGFR or eGFR between RIC and sham-
RIC (Table 2). Also, no differences between groups were observed with respect to mortality,
need for dialysis, rejections, NODAT or the renal injury biomarker P-NGAL. Analyses includ-
ing only the youngest 50% of the transplant recipients [20] also did not reveal any tendencies
on effects of RIC regarding tCr50 (RIC: mean 129 hrs, 95% confidence interval (CI) 96–172,
n = 60; vs. sham-RIC: 92 hrs, 95% CI 63–135, n = 47; p = 0.16) or mGFR at one year (RIC: 56
ml/min/1.73m2 95% CI 49–63, n = 40; vs. sham-RIC: 52 ml/min/1.73m2, 95% CI 46–59,
n = 32; p = 0.43).
Fig 1. CONSORT flow diagram of inclusion and randomisation.
https://doi.org/10.1371/journal.pone.0226882.g001
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Table 1. Recipient and donor characteristics. Baseline characteristics, tCr50 and the incidence of DGF. Data are
mean (standard deviation), n (%), or median (interquartile range). No statistically significant differences were identi-
fied between the groups. tCr50 = estimated time to a 50% reduction in plasma creatinine post-transplantation.
DGF = delayed graft function defined as need of dialysis first week post-transplantation. DBD = donation after brain
death. DCD = donation after circulatory death. Remuzzi score on biopsies taken 30 min after reperfusion of the graft
(baseline-biopsy). + score if including only biopsies with minimum six or ten glomeruli in the analysis.
Recipient RIC (n = 109) Sham-RIC (n = 113)
Gender, male 65 (60%) 69 (61%)
Age (years) 58.1 (49.5–65.0) 61.4 (49.4–66.6)
Preemptive transplantation 17 (16%) 23 (20%)
First transplantation 95 (87%) 98 (87%)
Diabetes mellitus 13 (12%) 13 (12%)
Total HLA-A, B, DR mismatches
0 6 (5.5%) 6 (5.3%)
1–2 17 (16%) 24 (21%)
3–4 70 (64%) 58 (51%)
5–6 16 (15%) 25 (22%)
Immunosuppression at discharge
Tacrolimus 98 (90%) 106 (94%)
Mycophenolate mofetil 105 (96%) 111 (98%)
Corticosteroids 101 (93%) 109 (96%)
Cyclosporine 7 (6.4%) 5 (4.4%)
None (graft loss) 4 (3.7%) 2 (1.8%)
Donor
Gender, male 60 (55%) 61 (54%)
Age (years) 58 (52–66) 58 (52–65)
DBD 98 (90%) 102 (90%)
DCD 11 (10%) 11 (10%)
Cause of death, DBD (n = 98)
Cerebrovascular insult 64 (65%) 70 (69%)
Cerebral anoxia 22 (22%) 20 (20%)
Trauma 11 (11%) 12 (12%)
Benign cerebral neoplasm 1 (1.0%) 0
Warm ischemia time DCD donor (min) 20 (15–21) 14 (13–18)
Missing data 0 1
Cold ischemia time (hours), DBD+DCD 13.3 (4.0) 13.6 (4.8)
n > 24h 3 (2.8%) 4 (3.5)
Missing data 2 (1.9%) 1 (0.9%)
Remuzzi score (baseline-biopsy)
Score all biopsies (n = 91&94) 2 (1–3) 2 (1–4)
Score 6 glom+ (n = 80&82) 2 (1–3.5) 2 (1–4)
Score 10 glom+ (n = 53&63) 3 (1–4) 3 (1–4)
Missing dataa 18 (17%) 19 (17%)
Post-transplantation
tCr50 (hours) (n = 104&107) 122 (98–151) 112 (91–139)
DGF 36 (33%) 40 (35%)
aBiopsies were either not performed (n = 22) or insufficient (n = 15).
https://doi.org/10.1371/journal.pone.0226882.t001
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tCr50 as predictor of GFR at twelve months
The tCr50, which is a previously developed marker of early graft function for the CONTEXT
study [13], correlated weakly, but highly significantly, with both mGFR and eGFR at twelve
months (Table 3), i.e. a longer tCr50 is associated with a lower GFR at one year. In contrast,
the presence or absence of DGF, i.e. need of dialysis first week post-transplant, did not corre-
late significantly with mGFR (DGF: 48 ml/min/1.73m2 95% CI 44–52, n = 106; vs. no DGF 52
ml/min/1.73m2 95% CI 45–58, n = 35; p = 0.39) at twelve months.
Discussion
In this randomised clinical CONTEXT trial, RIC did not improve GFR at one year after renal
transplantation. Also, RIC did not affect the risks of graft loss, death, rejection or NODAT.
This suggests that RIC does not offer any long-term protection in deceased donor kidney
Table 2. Outcomes at three and twelve months. Recipient and renal graft outcomes at three and twelve months depending on RIC or sham procedure. Values are n (%),
estimated median (95% CI) or mean (95% CI). mGFR and eGFR values are ml/min/1.73m2. mGFR, measured GFR; eGFR, estimated GFR.
Three months RIC (n = 109) Sham-RIC (n = 113) p
Deaths 1 (0.9%) 0 0.49
On dialysis 7/109 (6.4%) 7/113 (6.2%) 0.94
Rejectiona 10 (9.2%) 9 (8.0%) 0.74
NODATb 8 (7.3%) 12 (10.1%) 0.39
P-creatinine, μmol/L 136 (127–146) n = 101 140 (131–149) n = 106 0.60
P-NGAL, μg/L 163 (147–180) n = 83 176 (160–192) n = 90 0.25
P-cystatin C, mg/L 2.00 (1.88–2.13) n = 83 2.17 (2.01–2.34) n = 90 0.11
mGFR 41 (37–44) n = 78 43 (39–47) n = 70 0.35
eGFR, MDRDc 42 (39–46) n = 101 40 (38–44) n = 106 0.34
eGFRCrd 45 (41–48) n = 101 42 (39–46) n = 106 0.30
eGFRCyse 30 (28–33) n = 83 27 (25–30) n = 90 0.09
eGFRCr-Cysf 36 (33–39) n = 83 33 (31–36) n = 90 0.21
Twelve months
Deaths 2 (1.8%) 2 (1.8%) 1.00
On dialysis 8/109 (7.3%) 10/113 (8.8%) 0.68
Rejectiona 17 (15.6%) 14 (12.4%) 0.49
NODATb 11 (10.1%) 14 (12.4%) 0.59
P-creatinine, μmol/L 135 (125–145) n = 99 134 (124–144) n = 101 0.89
P-NGAL, μg/L 179 (163–197) n = 79 181 (166–197) n = 79 0.87
P-cystatin C, mg/L 1.85 (1.72–1.99) n = 79 1.92 (1.78–2.07) n = 78 0.48
mGFR 46 (41–51) n = 67 44 (39–48) n = 74 0.44
eGFR, MDRDc 43 (39–46) n = 99 42 (39–45) n = 101 0.77
eGFRCrd 45 (41–49) n = 99 44 (40–48) n = 101 0.75
eGFRCyse 34 (31–37) n = 80 33 (30–36) n = 77 0.56
eGFRCr-Cysf 38 (35–42) n = 80 38 (34–41) n = 77 0.85
U-albumin/creatinine, mg/g 52 (37–73 n = 68 46 (32–66) n = 68 0.63
aTotal number of patients with one or more rejections at three and twelve months.
bNODAT: total number of patients with NODAT (new-onset diabetes after transplantation) at three and twelve months.
cThe simplified MDRD creatinine based formula.
dThe CKD-EPI creatinine based formula (eGFRCr).
eThe CKD-EPI cystatin C based formula (eGFRCys).
fThe CKD-EPI creatinine and cystatin C based formula (eGFRCr-Cys).
https://doi.org/10.1371/journal.pone.0226882.t002
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transplantation. At the same time tCr50, the primary endpoint of the CONTEXT study, was
shown to correlate significantly with GFR at one year.
To our knowledge, the CONTEXT study is the largest investigation to date for RIC in
deceased donor kidney transplantation using a multicentre approach. The results were further
strengthened by the randomised double blinded design as well as the use of both mGFR and
P-cystatin C which are considered to provide more accurate estimates of GFR compared to
eGFR based on P-creatinine alone.
Transplantation from deceased donors is accompanied by more profound ischaemia reper-
fusion injury and an increased risk of DGF compared to living donor kidney transplantation.
Still, our results are clear and in concordance with findings in living donor transplantation
reported in the REPAIR study [21], which investigated the effect of early and late phase RIC
applied to both the donor and recipient at different time points prior to transplantation. The
REPAIR study also failed to demonstrate any significant effect of RIC on kidney function at
one year. However, a trend towards higher GFR (mGFR 58.3 vs. 55.9 mL/min/1.73m2,
p = 0.13) was observed in the group receiving RIC with a similar timing to the one used in the
CONTEXT study, when compared to the control group. Other and smaller studies have also
not been able to demonstrate a beneficial effect of RIC in renal transplantation either on
patient or kidney graft outcomes nor on various renal biomarkers [22–25].
Thus, the positive short term effects of RIC reported by our group in a porcine donation
after brain death transplant model [8] were not reproduced in patients in respect of either the
early graft function [10] or GFR at one year. Although animal studies have resulted in promis-
ing results to ameliorate renal ischaemia reperfusion injury, more research is required to
understand the mechanisms involved as little of the positive animal research data can be repli-
cated in the clinic nor can it be shown to improve transplant outcome [26]. A number of fac-
tors, such as uraemia, co-morbidity including diabetes, age [20], anaesthesia [27] or other yet
unidentified factors might explain this lack of effect in the clinical setting and they may also
blur potential beneficial effects of RIC in patients. Most animal studies are performed in
healthy animals not receiving immunosuppressants or other drugs that may potentially influ-
ence outcomes. It is possible that such medications may either block the protective mechanism
induced by the RIC or could have yielded other anti-ischaemic effects [28–30], thus blunting
or obliterating any beneficial effect of RIC. In addition to recipient-related and potentially con-
founding factors, there are additional donor-related variables that may influence and attenuate
the effect of RIC such as organ injury and inflammatory activation during brain death [31]. In
Table 3. tCr50 and kidney graft function at twelve months. Linear regression identifying a negative correlation
between tCr50 and kidney graft function at twelve months. tCr50 = the estimated time to a 50% reduction in P-creati-
nine. mGFR = measured GFR.
tCr50
n p r r2adj.
mGFR 141 <0.0001 -0.39 0.15
eGFR, MDRDa 200 <0.0001 -0.30 0.09
eGFRCrb 200 <0.0001 -0.30 0.09
eGFRCysc 157 <0.0001 -0.34 0.11
eGFRCr-Cysd 157 <0.0001 -0.36 0.13
aThe simplified MDRD creatinine based formula.
bThe CKD-EPI creatinine based formula (eGFRCr).
cThe CKD-EPI cystatin C based formula (eGFRCys).
dThe CKD-EPI creatinine and cystatin C based formula (eGFRCr-Cys).
https://doi.org/10.1371/journal.pone.0226882.t003
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most animal models organs are retrieved shortly after brain death, e.g. after four hours in our
porcine model [8], while in humans retrieval is often delayed. The protective mechanisms
induced by RIC (if any) were unfortunately insufficient to result in meaningful clinical effects.
It is possible that another explanation as to why our study failed to show a protective effect
of RIC may be the timing of application of the RIC stimulus which could be important for the
protective effects. Transplantation is a unique setting for the simple reason that the organ is
not connected to the recipient until reperfusion. It is believed that RIC may provide a first win-
dow of protection conferred by humoral factors released from the conditioned tissue. It is pos-
sible that such factors were no longer in circulation at the time of reperfusion although this
was only 38 (IQR 19–54) minutes after the end of the RIC procedures last cuff release [13].
The suggested humoral factors have short plasma half-lives [32]. Also, since the transplanted
kidney is denervated, any neuronal pathway for RIC effects is excluded.
In addition our study demonstrated a weak, but highly statistically significant, correlation
between tCr50 and both mGFR and eGFR at twelve months. No such correlation was demon-
strated when comparing the incidence of DGF with GFR at twelve months. This may suggest
that tCr50 is a more sensitive marker of the impact of early graft function on long term GFR
than the commonly used definition of DGF, i.e. the need for dialysis within the first week post-
transplantation. Thus, tCr50 although not simple to calculate [13] could be of use in future
studies on interventions to improve early and long term graft function. In addition to tCr50’s
correlation with one-year GFR, it has the advantage of being a continuous variable allowing all
patients to be included in the analysis except for the few who never obtain a 50% reduction in
P-creatinine.
In conclusion, our results indicate that RIC of the organ recipient does not offer any advan-
tages in kidney transplantation either on short or one year outcomes. tCr50 is negatively asso-
ciated with GFR at one year and may be used as a marker of early graft function with an
impact on long term outcome.
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